期刊文献+

凯纷对妇科恶性肿瘤患者术后曲马多镇痛的影响

Effect of Kaifun on Analgesia Efficacy During PCIA with Tramadol in Patients Undergoing Gynecologic Malignancy Operations
下载PDF
导出
摘要 目的研究凯纷用于妇科恶性肿瘤腹腔镜手术时超前镇痛的作用效果。方法 50例妇科宫颈癌或内膜癌的患者随机分为两组,每组25例。Ⅰ组在手术开始前10 min静脉缓注凯纷50 mg,手术中肿瘤切除后再静脉缓注凯纷50 mg;Ⅱ组分别在Ⅰ组相同的时间缓注生理盐水10 mL,分别记录术后1、2、8、24 h的视觉模拟评分。24 h曲马多用量和不良反应。结果术后1、2、8、24 h VAS评分Ⅰ组均低于Ⅱ组(P<0.05),术后24 hⅠ组的曲马多用量(275.8±45.5)mg低于(310.5±57.2)mg(P<0.05),镇痛结束后,两组不良反应中只有恶心呕吐差异有显著意义(P<0.05)。结论凯纷对妇科恶性肿瘤手术的超前镇痛和均衡镇痛,能减少术后曲马多用量,减轻不良反应的发生,提高镇痛质量。 Objective To observe the preemptive analgesia effect of Kaifun on laparoscopic surgery for gynecologic malignancies.Methods The 50 patients with gynecological uterocervical cancer or endometrial cancer were randomly divided into two groups,25 patients in each group.In group Ⅰ,patients received intravenous injection of Kaifun 50 mg slowly at 10 min before surgery and after tumor removal surgery.In group Ⅱ,patients respectively received intravenous injection of saline 10 mL at the same time.The analgesia efficacy of two groups was assessed at 1,2,8,24 h after operation by visual analog scale(VAS),and 24 h Tramadol dosage and adverse effects were recorded.Results At 1,2,8,24 h after operation,VAS scores in group Ⅰ were lower than those in group Ⅱ(P0.05);after 24h,Tramadol dosage(275.8±45.5)mg of group Ⅰ was lower than that(310.5±57.2)mg of group Ⅱ(P0.05).After analgesia there were significant differences between two groups in nausea and vomiting(P0.05).Conclusion Kaifun can produce preemptive analgesia and balanced analgesia for gynecological malignancies,reduce postoperative Tramadol consumption,reduce the incidence of adverse reactions and improve the quality of analgesia.
作者 刘冬俊
出处 《哈尔滨医药》 2011年第6期414-415,共2页 Harbin Medical Journal
关键词 凯纷 超前镇痛 均衡镇痛 曲马多 Kaifun Preemptive analgesia Balanced analgesia Tramadol
  • 相关文献

参考文献6

二级参考文献24

  • 1徐国柱,李晓玲,段砺瑕,朱天岳,谢启伟,周应芳,王冰,邓艳萍,沈黎阳,袁旭.氟比洛芬酯脂微球载体注射液治疗中度术后疼痛的Ⅱ期临床试验[J].中国新药杂志,2004,13(9):846-848. 被引量:258
  • 2[1]Ohmukai O.Lipo-NSAID preparation[J].Adv Drug Deliv Rev,1996,20(2-3):203-207.
  • 3[4]Kuriyama K,Hiyama Y,Aoyama Y,et al.Pharmacological studies of a non-steroidal analgesic and antipyretic drug of LFP83[J].Nippon Yakurigaku Zasshi,1989,93(2):61-73.
  • 4[6]Davis NM.Clinical pharmacokinetics of flurbiprofen and its enantiomers[J].Clin Pharmacokinet,1995,28(2):100-114.
  • 5[7]Mikawa K,Nishina K,Maekawa N,et al.Dose-response of flurbiprofen on postoperative pain and emesis after paediatric strabismus surgery[J].Can J Anaesth,1997,44(1):95-98.
  • 6[8]Machida K,Tsutsui T,Kaneko A,et al.Convulsion following the combination of single preoperative oral administration of enoxacine and single postoperative intravenous administration of flurbiprofen axetil[J].Jpn J Anesth,2001,50(4):425-428.
  • 7Skjodt NM, Davies NM. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam. Clin Pharmacokinet,1998,34: 421-428.
  • 8Pruss TP, Stroissnig H, Radhofer-Welte S, et al. Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam. Postgrad Med J,1990,66(Suppl 4) : 18-21.
  • 9Kehlet H,Werner M, Perkins F. Balanced analgesia. Whatis it and what are its advantages in postoperative pain?Drugs, 1999,58 : 793-797.
  • 10McCormack K. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain, 1994,59 : 6-43.

共引文献720

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部